<DOC>
	<DOCNO>NCT00228865</DOCNO>
	<brief_summary>To determine restore normal metabolic function patient either Type I Type II Diabetes improve overall cognitive function . Patients treat week pulsatile intravenous insulin therapy mimic normal insulin secretion high amount oral glucose consumption .</brief_summary>
	<brief_title>Clinical Effects Pulsatile Insulin Delivery Cognitive Function- Phase 1</brief_title>
	<detailed_description>It know glucose metabolic pathway ( glycolysis ) primary fuel generator brain nerve tissue , heart vascular tissue , eye , kidney liver Deficient metabolic state see glucose metabolism diabetic lead sequela . These damaging effect exacerbate alter cellular metabolite , specifically increase catabolic decrease anabolic factor . It show past twenty year normalization metabolism diabetic patient accomplish mimic normal endogenous insulin pattern ( ie. , pulse ) . Pulsatile insulin infusion demonstrate reverse diabetic metabolic state primary fat utilization carbohydrate utilization . This correlated stabilization kidney function patient overt diabetic nephropathy , stabilization blood glucose , stabilization blood pressure pattern , reversal hypoglycemic unawareness . In patient cognitive disorder ( Alzheimer 's type ) , infusion intravenous insulin short interval ( hour ) improve cognitive function . Patients type disorder few insulin receptor affect area brain insulin resistance measurement insulin glucose level spinal fluid . This study design study effect Pulsatile insulin patient diabetes mellitus impaired cognitive function . Diabetic individual without primary cause cognitive impairment ( brain tumor , previous neurosurgery , medication impair memory ) able swallow without difficulty undergo pulsatile insulin treatment weekly period 6-12 month renewal successive six month period . Serial cognitive study use Mindstream testing , Wechsler Memory Scale II localize cognitive function test do start treatment every 3 month thereafter.This study begin 2002 continue . The respiratory quotient ( RQ ) measurement CO2 exhale O2 inhale proportionate fuel source use body , primarily liver short period time . The high RQ , glucose less alternative fuel source utilize . Following RQ change help determine effectiveness physiological insulin administration increase anabolic function diabetic individual . By improve body 's glucose metabolism thereby cause beneficial effect anabolic factor , possibility serious complication decrease . In addition use oral carbohydrate time along physiologic insulin administration stimulate appropriate gut hormone augment effect , response duplicate intravenous glucose . The purpose study induce physiologic administration insulin along augment effect oral carbohydrate , return normal fuel organ metabolism note RQ change , evaluate effectiveness alter deleterious effect bodily function diabetic individual . The RQ determine use metabolic cart . Individuals breathe mask 3-5 minute rest period 30 minute . The ratio exhale volume CO2 inhale volume O2 determine RQ . The physiologic range 0.7 to1.3 . Individuals use fat primary fuel ratio 0.7 , protein mixed fuel 0.8-0.9 carbohydrate 0.9-1.0 . Those take excessive calorie RQ 's high 1.05 . The RQ follow serially treatment . Three treatment give visit center . The amount intravenous insulin oral glucose give determine RQ change previous treatment . The treatment encourage glucose metabolism diabetic normalize multiple organ , especially muscle , retina , liver , kidney nerve ending . The process fundamentally require administration high dose insulin pulse similar find non diabetic human pancreas surround portal circulation . Oral carbohydrate give simultaneously augment process prevent hypoglycemia . The process monitor frequent glucose level respiratory quotient ( RQ ) . RQ measure metabolic cart determines ratio VCO2/ VO2 . This ratio specific fuel use one time body . The glucose level monitor keep glucose level appropriate RQ determines need readjust infusion protocol patient subsequent insulin infusion session .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>diagnose type 1 type 2 diabetes mellitus . Self report diagnosed memory change Taking oral agent and/or insulin diabetic control Under Endocrinologist 's supervision diabetes management Endocrinologist must assess approve patient participation study Ability swallow without difficulty Ability commit weekly time requirement associate study Other cause cognitive impairment relate diabetes Inability take cognitive test Lack intravenous access Pregnancy Alcohol abuse , drug addiction use illegal drug Positive HIV Inability breathe machine respiratory quotient</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pulsatile intravenous insulin</keyword>
	<keyword>Oral carbohydrate loading</keyword>
	<keyword>Mindstream test</keyword>
	<keyword>Wechsler Memory Scale II</keyword>
	<keyword>Respiratory Quotients</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Diabetes Mellitus cognitive impairment</keyword>
	<keyword>Diabetes Mellitus complication</keyword>
</DOC>